baber/WOPTO huggingface dataset:
Patent AU-2005207318-B2 (AU)
Title: Methods for diagnosis and prognosis of cancers of epithelial origin
Inventor: ROY ROOPALI
IPC: G01N33/48
Filed: 2005-01-10
Granted: 2012-02-02
Abstract: ADAM 12 expression and activity are up regulated in patients that have cancers of epithelial origin, such as breast cancer, colon cancer, prostate cancer, liver cancer, bladder cancer, pancreatic cancer, ovarian cancer, cervical cancer, lung cancer, and skin cancer, as well as others: Accordingly. the present invention is directed to methods for prognostic evaluation, and diagnosis of cancers of epithelial origin. In particular, the presence of ADAM 12 in a biological sample is indicative of cancer of epithelial origin. Further, the amount of ADAM 12 protein detected in biological samples, e.g. urine, correlate with disease status such that ADAM 12 levels can be used to predict the presence of, as well as the metastatic potential of cancer. Thus, measuring the level of ADAM 12 in biological samples (e.g. urine or blood) provides a quick, easy, and safe screen that can be used to both diagnose and prognose cancer in a patient.
Patent AU-2005207856-B2 (AU)
Title: Novel inhibitors of chymase
Inventor: EUGENE POWELL
IPC: C07F9/6561
Filed: 2005-01-18
Granted: 2011-07-14
Abstract: The present invention is directed to a compound of formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof, and methods for treating inflammatory and serine protease mediated disorders.
Patent AU-2005266927-B2 (AU)
Title: Modification of lignin biosynthesis
Inventor: SRINIVASA REDDY M S
IPC: A01H5/10
Filed: 2005-07-25
Granted: 2011-07-14
Abstract: The invention provides methods for decreasing lignin content and improving lignin profiles. Also provided are the plants prepared by the methods of the invention. Such plants may exhibit improved digestibility relative to prior plants.
Patent AU-2005278962-B2 (AU)
Title: Isoindolin-1-one derivatives
Inventor: HARDCASTEL IAN ROBERT
IPC: C07D401/12
Filed: 2005-08-26
Granted: 2012-03-01
Abstract: A compound of formula (1) or a prodrug and/or pharmaceutically acceptable salt thereof, wherein X is selected from O, N or S; R is selected from hydrogen, halo, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted hydroxyalkyl, substituted or unsubstituted alkylamine, alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroaralkyl; R is selected from hydrogen, halo, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted hydroxyalkyl substituted or unsubstituted alkylamine, alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroalkyl; R is selected from hydrogen, halo, hydroxy, substituted or unsubstituted alloy substituted or unsubstituted hydroxyalkyl, substituted or unsubstituted alkylamine alkoxy, substituted or unsubstituted aryl or heteroaryl, and substituted or unsubstituted aralkyl or heteroalkyl; and R-R, is used to represent groups R, R, R and R which are independently selected from H, OH, alkyl, alkoxy, alkylamine, hydroxyalkyl, halo, CF, NH, NO, COOH, C=0.
Patent AU-2005294699-B2 (AU)
Title: Biodegradable cationic polymers
Inventor: YU LEI
IPC: A61K41/00
Filed: 2005-09-16
Granted: 2012-01-19
Abstract: Polymers comprising a polyethylenimine, a biodegradable group, and a relatively hydrophobic group are useful for the delivery of bioactive agents to cells.
Patent AU-2006215578-B2 (AU)
Title: Screening method for identifying protease secretion-deficient mutants of microorganisms
Inventor: HARTMANN MARCUS
IPC: C12Q1/37
Filed: 2006-02-16
Granted: 2011-03-03
Abstract: A method for identifying a protease secretion deficient strain of a microorganism involves producing a mutant of the microorganism, followed by adding the mutant to gel-filled wells of a microtitration plate, incubating the mutant in the gel-filled wells under conditions call sing the mutant to secrete proteins, separating the mutant from the gel, and measuring activity of a secretion protease of the microorganism in the gel, wherein either (i) the gel is a substrate for the secretion protease or (ii) the gel contains a substrate for the secretion protease.
Patent AU-2006235527-B2 (AU)
Title: User interface improvements for medical devices
Inventor: WALD ERIC R
IPC: G16Z99/00
Filed: 2006-04-01
Granted: 2011-09-29
Abstract: A method and apparatus is disclosed for operating a medical device with a screen having an improved graphical user interface, which selectively reallocates screen display for both single and multi-channel pumps. Channel indicators associate operation information with a specific delivery channel. Patient or drug order verification is facilitated with a rendering of the patient or the entire drug order/label on the screen. Decimal numbers are presented in vertically offset decimal format. A dual function button cancels the current operation and, after a delay, clears entered parameters. An area sensitive scrollbar cycles through information at various speeds. Screen brightness is adjusted based on an ambient light detector. A screen saver mode activates based on several operating conditions. The screen is incorporated in a removable user interface.
Patent AU-2006243757-B2 (AU)
Title: Compositions and methods for the analysis of degraded nucleic acids
Inventor: FERRE FRANCOIS
IPC: C12P19/34
Filed: 2006-05-03
Granted: 2012-02-09
Abstract: The invention relates to compositions and methods for gene expression analysis. In some embodiments, the invention provides compositions and methods for amplifying targets in a degraded nucleic acid sample. In some embodiments, the invention provides methods for determining the quality of nucleic acids (e.g., the degree of degradation) in a nucleic acid sample. The invention also provides methods for producing a gene expression profile from a degraded RNA sample.
Patent AU-2006290564-B2 (AU)
Title: Exercise device
Inventor: ALEXANDER BARRIE
IPC: A63B23/00
Filed: 2006-09-12
Granted: 2011-11-10
Abstract: The invention provides an exercise device (10) comprising an elongate member (20) and an engagement member (30) having an engagement region (40), the engagement member defining an aperture (35) therethrough, the elongate member extending through the aperture, such that when the engagement region is under substantially no load, the engagement member is slideable along the elongate member and when the engagement region is placed under load, the engagement member is substantially non-slideable along the elongate member. Also provided is a method of pelvic realignment involving use of said exercise device.
Patent AU-2006304321-B2 (AU)
Title: Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
Inventor: DONALD CARLTON D
IPC: A61K48/00
Filed: 2006-10-16
Granted: 2012-10-04
Abstract: Provided is a method of treating cancer in a subject by inhibiting expression of PAX2. An example of a cancer treated by the present method is prostate cancer. Similarly, provided is a method of treating cancer in a subject by increasing expression of DEFBl in the subject. In the method wherein the expression of DEFBl is increased, it can be increased by blocking the binding of PAX2 to the DEFBl promoter. Blocking the binding of PAX2 to the DEFBl promoter can be by administration of an oligonucleotide containing the PAX2 DNA binding site of DEFBl. This oligonucleotide can be complementary to the sequence of PAX2 that binds to the DEFBl promoter. Alternatively, the oligonucleotide can interact with the PAX2 in a way that inhibits binding to DEFBl.
Patent AU-2006308523-B2 (AU)
Title: Mixed silanes
Inventor: HUPFIELD PETER CHESHIRE
IPC: C09D183/08
Filed: 2006-10-18
Granted: 2012-08-30
Abstract: The present invention relates to a composition comprising at least one fluorosilane and at least one aminosilane, a condensation product of said fluorosilane and said aminosilane, and a surface protective agent made thereof.
Patent AU-2006312678-B2 (AU)
Title: Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
Inventor: HAUER HERMANN
IPC: A61K36/74
Filed: 2006-11-07
Granted: 2013-03-28
Abstract: The invention relates to extracts from the bark of corynanthe species, especially corynanthe pachyceras, and the use thereof for treating and preventing diseases of the urinary tract collecting system, sexual disorders, lipid metabolism disorders, cardiovascular diseases, and acute and chronic pain conditions. The invention further relates to medicaments, dietary products, and pharmaceutical preparations containing said extracts.
Patent AU-2006317072-B2 (AU)
Title: Highly selective molecular confinement for the prevention and removal of taint in foods and beverages
Inventor: JOHN CUNNINGHAM
IPC: C12H1/04
Filed: 2006-11-03
Granted: 2011-09-08
Abstract: A means of preventing TCA taint from contaminating liquid foods and beverages is provided comprised of incorporating molecular sieves into the manufacturing process and/or packaging materials in order to selectively adsorb the taint molecules while preserving the food's or beverage's flavor and aroma profiles. Also provided are methods and devices for remediating TCA taint present in the consumer's liquid foods and beverages.
Patent AU-2007201869-B2 (AU)
Title: Tilt anvil assembly
Inventor: MARCZYK STANISLAW
IPC: A61B17/11
Filed: 2007-04-27
Granted: 2012-07-12
Abstract: TILT ANVIL ASSEMBLY A tilt anvil assembly (10) is disclosed which includes a center rod (14) and a head assembly (12) pivotally mounted to the center rod. The head assembly includes a housing (18), a post (16), an anvil plate (24) and a backup member (20). The backup member (20) is movable about the post from a first position preventing pivotal movement of the head assembly to a second position accommodating pivotal movement of the head assembly. A pivotal latch assembly is also provided to prevent movement of the backup member from its second position to its first position. C;3 C-4 c-'Ji (0 C'4u (0 0 C1 mC
Patent AU-2007202088-B2 (AU)
Title: Hybrid corn plant and seed PP59302
Inventor: NAGLE BARRY J
IPC: A01H5/10
Filed: 2007-05-10
Granted: 2012-11-08
Abstract: This invention provides hybrid maize plant designated PP59302. This invention further provides hybrid seed of PP59302, hybrid plants produced from such seed, and variants, mutants, and trivial modifications to hybrid PP59302, as well as methods of using the hybrid and products 5 produced from the hybrid.
Patent AU-2007245488-B2 (AU)
Title: Implant for tissue engineering
Inventor: MEREDITH JAMES O
IPC: A61L27/56
Filed: 2007-04-25
Granted: 2012-04-19
Abstract: The invention provides a process for the production of a monolithic implant for use in tissue engineering, the process comprising the steps of plasticising at least one biocompatible material into a paste, extruding the paste through a die, and drying the extruded material to eliminate an aqueous and/or non-aqueous component. The invention also relates to a monolithic implant as thereby manufactured, and the use of such an implant as a scaffold for tissue-engineering and as a transplant tissue in reconstructive or replacement surgery.
Patent AU-2007269654-B2 (AU)
Title: Quantifiable internal reference standards for immunohistochemistry and uses thereof
Inventor: SHI SHAN RONG
IPC: G01N33/53
Filed: 2007-06-29
Granted: 2013-01-10
Abstract: Methods for identifying Quantifiable Internal Reference Standards (QIRS) for immunohistochemistry (IHC). Also disclosed are methods for using QIRS to quantify test antigens in IHC.
Patent AU-2007314728-B2 (AU)
Title: Membrane distillation method for the purification of a liquid
Inventor: VAN MEDEVOORT JOLANDA
IPC: B01D63/00
Filed: 2007-10-31
Granted: 2012-02-02
Abstract: The invention provides a method for the purification of a liquid by membrane distillation comprising: passing a heated vapourising stream of a liquid (retentate stream) through a retentate channel along a porous hydrophobic membrane (10), whereby vapour of the liquid flows via the pores of the membrane to the other side of said membrane, and condensing said vapour on the other side of said membrane to give a distillate stream in a distillate channel (5) which distillate is created by passing the heat of condensation (latent heat) towards a condenser surface (3), said condenser surface forming a non-porous separation between a feed stream of the liquid to be purified and said distillate stream, which feed stream is passed through a feed channel (2) in counter-current with the retentate stream, in which feed channel a space material (4) is arranged whereby at least part of the latent heat is transferred via the condenser surface to the feed stream, and whereby a positive liquid pressure difference is applied between the retentate stream and the feed stream at the corresponding points of the retentate channel and the feed channel over at least a part of each of the retentate channel (9) and feed channel. The invention further provides an apparatus suitable for use in said method.
Patent AU-2007358994-B2 (AU)
Title: Health cabin
Inventor: BAUDINO LAURENT
IPC: A61B5/00
Filed: 2007-09-11
Granted: 2014-01-16
Abstract: The invention relates to a health cabin (10) that comprises a housing (20), at least one armchair (30) and at least one measurement means (31, 32, 33, 34) for measuring data relative to the health of a user, characterised in that the cabin includes: means (41-50) for determining upon measurement at least one condition of said measurement; and means for storing in a data structure the result of said measurement in association with said condition.
Patent AU-2008236629-B2 (AU)
Title: Reprogramming of somatic cells
Inventor: MEISSNER ALEXANDER
IPC: C12N15/00
Filed: 2008-04-07
Granted: 2014-03-06
Abstract: The disclosure relates to a method of reprogramming one or more somatic cells, e.g., partially differentiated or fully/ terminally differentiated somatic cells, to a less differentiated state, e.g., a pluripotent or multipotent state. In further embodiments the invention also relates to reprogrammed somatic cells produced by methods of the invention, to uses of said cells, and to methods for identifying agents useful for reprogramming somatic cells.
Patent AU-2008243353-B2 (AU)
Title: Highly stable electrolytic water with reduced NMR half line width
Inventor: DE NONI ROBERTO
IPC: C25B9/19
Filed: 2008-04-25
Granted: 2014-02-06
Abstract: Electrolytic acid or alkaline water having a NMR half line width using
Patent AU-2008245458-B2 (AU)
Title: Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
Inventor: KYM PHILIP R
IPC: A61P3/10
Filed: 2008-04-30
Granted: 2013-01-10
Abstract: The present invention relates to compounds of formula (I): wherein R
Patent AU-2008259661-B2 (AU)
Title: Novel agent for salting out active principles in dressings containing at least one fatty substance
Inventor: LAURENSOU CHRISTELLE
IPC: A61K31/7016
Filed: 2008-05-23
Granted: 2013-05-09
Abstract: The present invention relates to the use, as an agent for salting out an active substance in a composition for a dressing, of a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulphonic acid and the 2-hydroxyethyl ester of propenoic acid. It also relates to dressings of the type comprising at least one fatty substance and/or an elastomeric matrix and at least one active substance, which incorporate the aforementioned copolymer.
Patent AU-2008266168-B2 (AU)
Title: Mono-di-and polyol phosphate esters in personal care formulations
Inventor: REIERSON ROBERT LEE
IPC: C11D1/12
Filed: 2008-06-12
Granted: 2014-07-10
Abstract: A hydrophilized personal care formulation, which can be in the form of a hand or body soap (liquid or bar), lipstick, body wash, makeup remover, skin cleaner, hair conditioner, skin or hair moisturizer. The formulation employs an organophosphorus material or a mixture of an organophosphorus material, for example, mono-, di-, and polyol phosphate esters.
Patent AU-2008309923-B2 (AU)
Title: Aqueous ophthalmic formulations
Inventor: TAKRURI HARUN
IPC: A61K31/573
Filed: 2008-10-08
Granted: 2014-04-03
Abstract: The present invention relates to aqueous ophthalmic formulations containing cyclosporine and methods for treating and/or preventing ophthalmic diseases or disorders of humans or animals. The present ophthalmic formulations and methods are highly suitable for ocular administration, more particularly administration in the front of the eye, and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to ophthalmic formulations and methods for preventing and/or treating ophthalmic diseases or disorders directly and/or indirectly related to inflammatory conditions.
Patent AU-2008311043-B2 (AU)
Title: Complex metallographic structured steel and method of manufacturing same
Inventor: SUN WEIPING
IPC: C23C2/06
Filed: 2008-10-06
Granted: 2013-02-21
Abstract: A multi-phase steel sheet having microstructure having in combination ferrite, martensite of between 3% and 65% by volume, and at least one microstructure selected from the group consisting of, bainite and retained austenite, and having fine complex precipitates selected from the group of TiC, NbC, TiN, NbN, (Ti.Nb)C, (Ti.Nb)N, and (Ti.Nb)(C.N) particles having at least 50% smaller than 20 nm in size, and physical properties having tensile strength greater than about 780 megapascals and at least one of the properties of elongation greater than about 10%, yield ratio greater than about 70%, and hole expansion ratio greater than about 50%.
Patent AU-2009201698-B2 (AU)
Title: Measuring arrangement for determining the constituents of a sample taken from a crop stream
Inventor: KORMANN GEORG
IPC: A01D46/00
Filed: 2009-04-28
Granted: 2013-09-12
Abstract: MEASURING ARRANGEMENT FOR DETERMINING THE CONSTITUENTS OF A SAMPLE TAKEN FROM A CROP STREAM The invention pertains to a sensing arrangement (104) 5 for detecting the ingredients of a sample (116) taken from a crop stream. The sensing arrangement (104) comprises a branch channel (106) connected to an opening (108) in a channel (94) through which a crop flow can be led, and a measuring device (110) for 10 detecting the ingredients of a sample (116) in the branch channel (106). It is proposed that in the branch channel (106) between the opening (108) and the measuring device (110), a processing device (128) for a size reduction and/or squeezing of the sample (116) is 15 provided. Fig. 2 130 o0o
Patent AU-2009208410-B2 (AU)
Title: Solar cell, concentrating solar power generation module, and solar cell manufacturing method
Inventor: OKAMOTO CHIKAO
IPC: H01L31/042
Filed: 2009-01-20
Granted: 2012-05-31
Abstract: A solar battery (210) is provided with a pillar optical member (230) comprised of an incident surface (231) on which sun light (Ls) is incident and an irradiation surface (232) arranged facing a solar battery element (211) for the irradiation of the sun light (Ls) to the solar battery element (211) and a holding unit (240) that holds the pillar optical member (230). The holding unit (240) is provided with an abutting frame member (241) that is abutted to a side surface (233) of the pillar optical member (230) and has a thickness (t) in a direction from the incident surface (231) to the irradiation surface (232) and a support member (242) that is arranged separately from the pillar optical member (230) for supporting the abutting frame member (241). The side surface (233) of the pillar optical member (230) is inclined to totally reflect the sun light (Ls) in the direction to the irradiation surface (232) while the incident surface (231) of the pillar optical member (230) is set to such a size that a light flux collection region (FLRd) formed by the sun light (Ls) on the incident surface is positioned inside.
Patent AU-2009223204-B2 (AU)
Title: Linear and cyclic guanidine derivatives, method of preparation and uses thereof
Inventor: BOTTA MAURIZIO
IPC: A61K31/395
Filed: 2009-03-12
Granted: 2014-07-24
Abstract: The present invention relates to linear and cyclic guanidine derivatives, method of preparation and uses thereof, pharmaceutical compositions to be used as antifungal agents, in particular against Candida species.
Patent AU-2009259383-B2 (AU)
Title: Ternary herbicidal compositions comprising aminopyralid and imazamox
Inventor: PFENNING MATTHIAS
IPC: A01N43/50
Filed: 2009-06-16
Granted: 2014-09-18
Abstract: Herbicidally active compositions, which comprise 4-amino-3,6-dichloropyridine-2-carboxylic acid (common name: aminopyralid), 2-[(
Patent AU-2009259471-B2 (AU)
Title: Mixing and dispensing apparatus with movable mixing chamber
Inventor: BERNHARDSGRUETTER RAPHAEL
IPC: A47J31/40
Filed: 2009-05-29
Granted: 2016-04-28
Abstract: The present invention relates to a beverage mixing and dispersing apparatus comprising : - a metering device, - a mixing chamber, - at least one diluent feeding means, - means for moving the mixing chamber, characterized in that the mixing chamber is movable between : - a metering position, where the metering device outlet emerges in the mixing chamber inlet, and - a mixing position, where the diluent feeding means are able to inject the diluent in the mixing chamber and the metering device outlet does not emerge in the mixing chamber inlet.
Patent AU-2009277430-B2 (AU)
Title: Roller mill with gas duct
Inventor: HORNING BENT
IPC: B02C15/14
Filed: 2009-06-01
Granted: 2015-03-26
Abstract: A description is provided of a roller mill (1) for grinding particulate material such as cement raw materials, cement clinker and similar materials, said roller mill (1) comprises a mill housing (2) surrounding a substantially horizontal grinding table (3), a number of rollers (4), each rotating about a roller shaft (5), configured for interactive operation with the grinding table (3) and means for introducing gases into the mill housing (2). The roller mill is characterized in that the means for introducing gases into the mill housing (2) comprises an annular duct (7) having openings (8) in a wall (9) facing the grinding table (3) and being located around the outer circumference of the grinding table (3). As a consequence hereof, a significant reduction of the pressure loss in a roller mill and thus a significant reduction of the energy consumption will be ensured.
Patent AU-2009288738-B2 (AU)
Title: Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
Inventor: JONES ROBERT M
IPC: A61P29/00
Filed: 2009-08-26
Granted: 2015-04-09
Abstract: The present invention relates to certain substituted tricyclic acid derivatives of Formula (I) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, myocardial ischemia-reperfusion injury injury, hypertensive nephropathy, glomerulosclerosis, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, microbial infections and associated diseases, viral infections and associated diseases, diseases and disorders mediated by lymphocytes, auto immune diseases, inflammatory diseases, and cancer.